STRS Ohio’s Genocea Biosciences, Inc. GNCA Stock Holding History

STRS Ohio’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-188	Closed	-$14K	–	1853
2014 Q3	$14K	Buy	+188	New	+$20.6K	﹤0.01%	1752

Other funds holding GNCA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

STRS Ohio's GNCA Position: Q4 2014 in Review

STRS Ohio sold out of Genocea Biosciences, Inc. (GNCA) in Q4 2014, closing a stake of 188 shares — an estimated $14K sold.

STRS Ohio first reported a position in GNCA in Q3 2014 and held it in 1 quarter. The position peaked at $14K in Q3 2014. 38 funds tracked by Wall St. Rank hold GNCA as of Q4 2014.

STRS Ohio reported no remaining Genocea Biosciences, Inc. position as of Q4 2014 after selling out during the quarter.
STRS Ohio sold 188 Genocea Biosciences, Inc. shares in Q4 2014, an estimated $14K.
STRS Ohio first reported a position in Genocea Biosciences, Inc. in Q3 2014 and held it in 1 quarter.
STRS Ohio's Genocea Biosciences, Inc. position peaked at $14K in Q3 2014.
38 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q4 2014.

Based on STRS Ohio's 13F filing for Q4 2014, filed 23 Jan 2015.